Spectrum Medical is a relatively young company, founded in 2020, operating in the Hardware and Health Care industries. The company specializes in clinical mass spectrometry and aims to enhance the accessibility of mass spectrometry detection technology. With a strong emphasis on research and development, operations, and sales, Spectrum Medical has managed to attract significant attention from investors. The company recently secured a substantial CNY225.00M Series A investment on 23 June 2022, with the backing of notable investors such as Sequoia China, Grand Mount Capital, and Hangzhou Financial Investment. Spectrum Medical's expertise spans across various domains, from maternal and child genetics to nutritional assessments, therapeutic drug monitoring, and metabolic analysis. The company's capabilities are bolstered by a sophisticated laboratory management system and a GMP-compliant production workshop, further solidifying its position in the market. As Spectrum Medical continues to expand its reach and advance its technology, it presents a compelling opportunity for venture capitalists seeking exposure to innovative solutions in the healthcare and hardware sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY225.00M | 3 |
|
23 Jun 2022 |
No recent news or press coverage available for Spectrum Medical.
We care about your data, and we'd love to use cookies make your experience better.